TOIIW (The Oncology Institute) Other Long Term Assets: $0.62 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TOIIW The Oncology Institute Inc TOIIW
60 GF Score
Price $0.06
! 4 Warning Signs
View Full Analysis

What is The Oncology Institute Other Long Term Assets?

The Oncology Institute TOIIW 60 Other Long Term Assets is $0.62 Mil as of Mar. 2026. GuruFocus rates TOIIW with a GF Score™ of 60/100. The stock has 4 warning signs investors should review.

The Oncology Institute's other long-term assets for the quarter that ended in Mar. 2026 was $0.62 Mil.

The Oncology Institute's quarterly other long-term assets increased from Sep. 2025 ($0.59 Mil) to Dec. 2025 ($0.61 Mil) and increased from Dec. 2025 ($0.61 Mil) to Mar. 2026 ($0.62 Mil).

The Oncology Institute's annual other long-term assets increased from Dec. 2023 ($0.56 Mil) to Dec. 2024 ($0.59 Mil) and increased from Dec. 2024 ($0.59 Mil) to Dec. 2025 ($0.61 Mil).

The Oncology Institute Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for The Oncology Institute's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Oncology Institute Other Long Term Assets Chart

The Oncology Institute Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial 0.32 0.48 0.56 0.59 0.61

The Oncology Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.59 0.59 0.61 0.62
TOIIW
60GF Score
The Oncology Institute Inc TOIIW
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Oncology Institute Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $0.62 Mil mean?
The Oncology Institute (TOIIW) has a Other Long Term Assets of $0.62 Mil as of Mar. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on The Oncology Institute and its competitors.
Is The Oncology Institute's Other Long Term Assets too high?
The Oncology Institute's current Other Long Term Assets is $0.62 Mil. Overall, The Oncology Institute has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does The Oncology Institute's Other Long Term Assets compare to CYH and SRTA?
The Oncology Institute's Other Long Term Assets of $0.62 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Providers & Services company?
A good Other Long Term Assets depends on the Healthcare Providers & Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on The Oncology Institute and its competitors. The Oncology Institute's current Other Long Term Assets is $0.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Oncology Institute stock overvalued right now?
The Oncology Institute (TOIIW) has a current Other Long Term Assets of $0.62 Mil. The current Other Long Term Assets is $0.62 Mil. The Oncology Institute's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For The Oncology Institute (TOIIW), the current Other Long Term Assets is $0.62 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Oncology Institute Business Description

Other Exchanges TOI:USA
Address 18000 Studebaker Road, Suite 800, Cerritos, CA, USA, 90703
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
60GF Score

Get the complete analysis for TOIIW

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.06
Price